Conflicting information from TGA versus FDA may undermine compliance with use of medication

Med J Aust. 2013 Jul 8;199(1):28-9. doi: 10.5694/mja13.10086.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adrenergic alpha-2 Receptor Agonists / therapeutic use*
  • Age Factors
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Australia
  • Child
  • Clonidine / therapeutic use*
  • Drug Approval*
  • Drug Labeling*
  • Humans
  • Patient Compliance
  • United States
  • United States Food and Drug Administration

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Clonidine